Clinical Trial

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Study acronym: SCANVIR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 4, 2022 (before its estimated December 9, 2022 completion). Its status may not reflect the trial's current state.
Summary
The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.
Trial Details
NCT Number NCT05361603
Lead Sponsor University Hospital, Limoges
Conditions Hepatitis C, Transmission, Intravenous Drug Abuser, Addiction, Alcohol, Addiction Opiate, Hepatitis C Virus Infection, Response to Therapy of
Enrollment 1,500 participants
Start Date 2017-05-24
Primary Completion 2022-12-09 (estimated)
Study Completion 2030-02-14 (estimated)
Updated on ClinicalTrials.gov 2022-05-04